Avita Medical | 1811094D - 营业利润



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 493.79M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


营业利润 更改 日
Accuray USD 4.71M 6.86M 2024-12
Celltrion KRW 12.9B 822.77M 2026-03
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Cochlear AUD 261.1M 135.55M 2025-12
CSL USD 2.64B 1.97B 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Kangmei Pharma CNY -35.26M 24.32M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Mayne Pharma AUD -3.3M 15.67M 2024-06
Medical Developments International AUD -36K 444K 2025-12
Nanosonics AUD 9.12M 3.82M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pacific Edge NZD -16.94M 2.46M 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Qiagen NV USD 141.4M 24.77M 2026-06
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 499.81M 490K 2026-03
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Telix Pharmaceuticals AUD 46.36M 38.32M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 362.83M 474.98M 2026-06